Syndax Pharmaceuticals (SNDX) Reports Q2 Loss of $0.47/Share

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.47), versus ($440.52) reported last year. Revenue for the quarter came in at $305 thousand, versus $17 thousand reported last year.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
• AiRWA receives Nasdaq deficiency notice over late 10-K filing